To enable and assist our clients with a hassle-free submission process, it was decided to contract Zwiers Regulatory Consultancy as our main strategic regulatory partner.
In this case study article Viroclinics Biosciences‘ team member Saskia Smits sheds light on a customized research model, designed to tackle the challenge of typing multiple Rhino- and Enteroviruses.
An interview with lead author Penelope Koraka, sharing her latest insights on Rabies, recently published in Frontiers in Microbiology.
The French ministry of research and innovation approves Viroclinics Biosciences as an intermediate vendor for The French Tax Credit Incentive (Crédit d’Impôt Recherche or CIR), a tax relief measure for companies focused on Research & Development activities.
Parcom Capital has acquired the successful clinical research organisation Viroclinics Biosciences. Viroclinics believes Parcom is the perfect partner to help it realise its growth ambitions.